The U.S. Department of Health and Human Services (HHS) has announced significant job cuts, eliminating 10,000 positions across various federal health agencies. This decision, made public on March 27, 2025, has raised concerns about its impact on public health and biomedical research in the country.
The layoffs began on Tuesday, with termination notices sent to employees at HHS, the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and the Centers for Disease Control and Prevention (CDC), among other agencies. These cuts come in addition to around 10,000 employees who have already left under a previous early retirement offer.
HHS Secretary Robert F. Kennedy Jr. stated that the layoffs are part of a plan to streamline the organization and focus on core missions, particularly in addressing chronic disease issues. However, many in the public health community view these cuts as a severe blow. Dr. Ashish Jha, former COVID-19 Response Coordinator, expressed deep concern, stating that the effectiveness of agencies like the CDC and NIH in managing disease outbreaks and advancing medical research may be compromised.
The FDA is particularly affected, with reports indicating that 3,500 jobs will be cut, including the entire communications team. The FDA’s top vaccine official, Dr. Peter Marks, has also been forced out. Former FDA commissioners have voiced their alarm over the changes, with some predicting that the agency may struggle to maintain its role in drug approval and safety monitoring.
At the NIH, around 1,200 positions are expected to be eliminated, impacting communications and IT staff as well as several high-ranking officials. The atmosphere at the NIH has been described as one of despair, with employees fearing for their futures.
The cuts have drawn criticism from various quarters, including members of Congress. House Energy and Commerce Committee Ranking Member Frank Pallone Jr. labeled the layoffs an unprecedented attack on the federal health workforce, arguing that they will harm healthcare services.
As the dust settles on this major restructuring, the long-term effects on public health and safety remain uncertain. Many worry that the country could face increased health risks and a diminished capacity to respond to future challenges.